Screener
Fulgent Genetics, Inc. FLGT Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $21,125 | $18,654 |
| Accrued liabilities | 34,901 | 34,057 |
| Customer deposit | 30,619 | 28,145 |
| Contract liabilities | 3,007 | 3,635 |
| Notes payable, current | 482 | 476 |
| Total current liabilities | 90,134 | 84,967 |
| Deferred tax liabilities | 6,982 | 6,936 |
| Unrecognized tax benefits | 5,727 | 7,283 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s deferred revenue?
- Fulgent Genetics, Inc. (FLGT) reported deferred revenue of $3.01M in Q1 2026.
- How has Fulgent Genetics, Inc.'s deferred revenue changed year-over-year?
- Fulgent Genetics, Inc.'s deferred revenue increased by 6.7% year-over-year, from $2.82M to $3.01M.
- What is the long-term trend for Fulgent Genetics, Inc.'s deferred revenue?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s deferred revenue has grown at a -32.8% compound annual growth rate (CAGR), from $26.58M to $3.64M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Fulgent Genetics, Inc.'s deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude